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Abstract
Background: Lead toxicity is of particular public health concern given its near ubiquitous distribution in nature and
established neurotoxicant properties. Similar in its ubiquity and ability to inhibit neurodevelopment, early childhood
stunting affects an estimated 34 % of children under 5 in low- and middle-income countries. Both lead and
stunting have been shown to be associated with decreased neurodevelopment, although the relationship between
these childhood burdens is underexplored. The association between lead exposure and stunting has been
previously established, yet limited data are available on susceptibility windows.
Methods: Whole blood lead samples were collected from rural Bangladeshi children at delivery (umbilical cord
blood) and at age 20–40 months (fingerstick blood). Stunting was determined using the Child Growth Standards
developed from the World Health Organization Multicentre Growth Reference Study. Children with height for age
< -2 z-scores below the median of the WHO Child Growth Standards were classified as stunted in all analyses.
Results: Median (IQR) umbilical cord and fingerstick blood lead levels were 3.1 (1.6–6.3) μg/dl and 4.2 (1.7–7.6) μg/
dl, respectively. In adjusted multivariable regression models, the odds of stunting at 20–40 months increased by 1.
12 per μg/dl increase in blood lead level (OR = 1.12, 95 % CI: 1.02–1.22). No association was found between cord
blood lead level and risk of stunting (OR = 0.97, 95 % CI: 0.94–1.00).
Conclusions: There is a significant association between stunting and concurrent lead exposure at age 20–40
months. This association is slightly attenuated after controlling for study clinic site. Additional research including
more precise timing of lead exposure during these critical 20–40 months is needed.
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Background
Children are particularly susceptible to, and increasingly
confronted by, a myriad of health burdens resulting from
exposure to environmental toxins. Toxic metals such as
lead (Pb) are of particular public health concern given
their near ubiquitous distribution and persistency in
nature [1]. Although lead naturally occurs in the earth’s
crust, its presence in the human environment has in-
creased steadily with the growth of industry [2].
Having been found in foodstuffs [3–7] and children’s
toys [8], lead has previously been described as a “multi-
media pollutant” due to its multitude of historical and
current uses and pathways of exposure [9]. It is a well-
documented environmental neurotoxicant whose adverse
effects have been highlighted by recent literature citing no
threshold below which lead has no effect on the develop-
ing brain [10–12].
The inconsistent regulations surrounding the use of
lead across the globe have resulted in disproportionate
exposure potentials, with developing countries at the
highest risk for heavy metal over-exposure [13]. Further
compounding this disparity in global exposure is the
overwhelming prevalence of chronic stunting, which
* Correspondence: kgleason@mail.harvard.edu
1Department of Environmental Health - EOME Program, Harvard T.H. Chan
School of Public Health, Landmark Center, 401 Park Drive, 3rd Floor East,
Boston, MA 02215, USA
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Gleason et al. Environmental Health  (2016) 15:103 
DOI 10.1186/s12940-016-0190-4
affects an estimated 34 % of children younger than
5 years in low- and middle-income countries [14].
Growth potential has been shown to be similar across all
countries, indicating that stunting occurs as a result of
chronic malnutrition rather than genetic differences [15,
16]. More than 200 million children under 5 years of age
are currently estimated to fail to reach their cognitive
development potential because of poor health, poverty,
and poor nutrition [17]. In addition, similar to the neu-
rodevelopmental effects of lead, a growing body of
evidence has shown that stunting, an indicator of
chronic malnutrition, is associated with reduced educa-
tional attainment [17] and neurodevelopment including
lower achievement levels, IQ, and higher order cognitive
processing [18–20].
Bangladesh is one such developing country that is
particularly vulnerable to high levels of lead exposure
due to the country’s poorly enforced environmental
regulations [21, 22] and high prevalence of malnutrition
[23]. The specific objectives of this study were to investi-
gate the association between blood lead level and chronic
malnutrition among children in rural Bangladesh and
to identify a critical window of exposure for the effect
of lead on chronic malnutrition. We hypothesized that
concurrent rather than in utero lead exposure would
be more highly associated with chronic malnutrition
among children in rural Bangladesh.
Methods
Subject selection
Details of the recruitment strategy, eligibility criteria,
and sample collection from children participating in this
study have been published previously [24, 25]. Briefly,
participants were members of a longitudinal birth cohort
established in rural Bangladesh to study the health
effects of prenatal and early childhood exposures to
metals in the environment. Between 2008 and 2011,
pregnant women in the Sirajdikhan and Pabna Upazilas
of Bangladesh were enrolled and followed through preg-
nancy. Gestational age was determined by first trimester
ultrasound. Between 2010 and 2013, when children were
aged 12 to 40 months, healthcare workers from Dhaka
Community Hospital (DCH) invited families to enroll
their children in follow-up studies; all children born to
mothers in the original study were eligible. Informed
consent was provided by the parents of all participants
before enrollment. The Committee for Clinical Investi-
gation at Boston Children’s Hospital (BCH) ceded review
of this study to the Harvard T.H. Chan School of Public
Health (Harvard Chan School). The Human Research
Committees at the Harvard Chan School and DCH
approved this study.
A total of 1613 pregnant women were enrolled in the
reproductive outcomes study. Over the course of the
study, 123 women were lost to follow-up, 125 women
no longer wished to participate in the study, and 132
pregnancies resulted in miscarriage, 75 in stillbirth, and
5 in twin births, resulting in 1153 mothers and their
children participating in this study. A total of 815
children participated in complete neurodevelopmental
assessments; 624 of these included fingerstick blood lead
measurements at age 20 to 40 months. Complete data
for cord blood lead concentration, fingerstick blood lead
concentration, water metal concentrations, and stunting
outcomes were available for 618 children, and this
comprises the study sample for the current analysis.
Environmental exposure assessment
Lead exposure was assessed using blood samples collected
at two time points: umbilical cord blood at birth, represent-
ing prenatal lead exposure, and fingerstick blood at 20 to
40 months of age, representing early childhood exposure.
Umbilical cord blood samples were collected in trace
metal-free tubes and were analyzed for lead at the Trace
Metals Laboratory at the Harvard Chan School. Umbilical
cord blood samples were first weighed (~1 g) and digested
for 24 h in 2 mL of concentrated nitric acid. The samples
were then treated with 1 mL of 30 % hydrogen peroxide
per 1 g of blood and left overnight. Samples were subse-
quently diluted to 10 mL with deionized water. Blood lead
concentrations were measured using a dynamic reaction
cell-inductively coupled plasma mass spectrometer (DRC-
ICP-MS, DRC II, Perkin Elmer). Analyses were performed
using an external calibration method, with lutetium as the
internal standard for lead. Continual calibration standards
and a standard reference solution (NIST 1643e: Metals in
Water) were used to monitor precision and accuracy of the
analysis. The final reported value in this study was an aver-
age of 5 replicate measurements for each individual sample.
Fingerstick blood lead concentrations were measured
using portable LeadCare II instruments (Magellan
Diagnostics, Billerica, MA, USA) that have a reportable
range of 3.3–65 μg/dL. A subset of samples was obtained
via venipuncture for confirmation. Before testing, study
staff washed the children’s hands to avoid contaminating
the blood sample with lead from the skin. Each child’s
finger was pricked with a single-use lancet, and a 50 μL
capillary tube was filled after discarding the first drop-
let. Daily quality-assurance measures were performed
according to the user’s manual.
Quality control measures for blood measurements in-
cluded analysis, procedural blanks, duplicate samples,
spiked samples, and analysis of a certified reference
material (NIST 955b: bovine blood for lead) to monitor
for contamination, accuracy, and recovery rates. Recov-
ery rates for lead in quality control and spiked samples
ranged from 81 to 108 %, and precision was measured
as percent relative standard deviation (SD), with a result
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of less than 3 % for lead. The average limit of detection
(LOD) was 0.2 μg/dL.
Water samples were collected at four time points: 1) en-
rollment of mothers, 2) 1 month postpartum, 3) 12 months
of age, and 4) 20 to 40 months of age. The average ar-
senic/manganese exposure value across these four visits
was used in all analyses [26]. Arsenic and manganese con-
centrations were measured using water samples collected
from tube wells identified by enrolled mothers as the
household’s primary source of drinking water. Water
samples were collected in 50 ml polypropylene tubes (BD
Falcon, BD Bioscience, Bedford, MA), preserved with
Reagent Grade nitric acid (Merk, Germany) to a pH < 2,
and stored at room temperature. Analysis of all arsenic
and manganese samples was conducted using induct-
ively coupled plasma mass-spectrometry (ICP-MS)
(Spectrum Analytical, Inc., Agawam, MA USA) follow-
ing U.S. Environmental Protection Agency (EPA) method
200.8 [27].
Stunting
Stunting status of children was determined using the
World Health Organization (WHO) macros (Version
3.2.2). This software utilizes the Child Growth Standards
developed from the WHO Multicentre Growth Reference
Study (MGRS) [16]. These standards aim to provide a
single international standard of physiological growth for
all children from birth to 5 years of age. Applying this
international standard, children with height for age < -2 z-
scores below the median of the WHO Child Growth
Standards were classified as stunted in all analyses.
Covariates
At the time of enrollment of the mothers, trained study
staff administered a questionnaire targeting maternal
demographics and medical history. Data on education,
smoking history, and maternal weight were also collected
during this visit.
Infant sex and length were recorded at birth. A food
frequency questionnaire was administered prior to the
birth of the child. A measure of maternal protein intake
during pregnancy was derived from frequency of con-
sumption (times consumed per week) of fish, meat, and
egg, to account for potential confounding by mother’s
nutritional status. Protein intake was coded as a categor-
ical variable indicating weekly protein consumption as
high (>26 units of protein), medium (12.5–26 units of
protein), and low (<12.5 units of protein).
During the follow-up study, trained interviewers admin-
istered the Home Observation for Measurement of the
Environment (HOME) Inventory that had been previously
translated and adapted for use in Bangladesh [28]. The
HOME Inventory measures the quality and quantity of
stimulation and support available to the child in the home
environment. The HOME Inventory is comprised of 7 sub
scales that were summed into one composite HOME
Inventory variable.
At the 20- to 40-month home visit, trained study staff
also administered the Edinburgh Postnatal Depression
Scale (EPDS) to mothers [29] as a measure of depressive
symptoms.
Statistical methods
All statistical procedures were performed using RStudio
version 0.98.1087. To investigate the potential for differ-
ences in demographics and exposure profiles between
the two study sites, descriptive statistics and metal distri-
butions were examined for all variables by clinic. We
considered the presence of effect modification by study
site and stratified our analysis.
A multivariate logistic regression model was con-
structed by including covariates selected through review
of the literature. Blood lead concentration at birth (cord
blood) was modeled as a continuous variable. Fingerstick
blood lead concentration took a non-linear form in the
association with stunting, and we modeled this variable
using a quadratic effect. In this analysis, the primary out-
come of interest, stunting, was modeled as a dichotom-
ous variable, indicating the presence or absence of
stunting. Maternal weight, maternal education, maternal
protein intake, and HOME Inventory score were all
modeled as continuous variables. Average water arsenic
and manganese levels were included as continuous vari-
ables in the model to account for differences in the
distribution of the metals between sites.
Initial models included EPDS as a measure of maternal
depression; however, inclusion of this variable reduced
our sample size by 44 % (n = 346), and this variable was
not included in our final model. We further considered
the possibility of unmeasured confounding by study site
and initially included an indicator variable for clinic site
in our model. After inclusion of all known predictors
and confounders, including EPDS, study site was not
found to be statistically significant (p = 0.19).
Results
Selected demographic characteristics stratified by study
site (Pabna and Sirajdikhan) are presented in Table 1.
Exposure distributions of lead, arsenic, and manganese
are shown in Table 2. Fingerstick blood lead concentra-
tions obtained using the portable LeadCare II instru-
ments were confirmed using a subset of samples
obtained via venipuncture (r = 0.80).
Examination of the stratified demographics highlights
several differences between study sites. Compared to chil-
dren from Pabna, children from Sirajdikhan were more
likely to be stunted (62.2 % vs. 42.6 %) but were less likely
to be exposed to cigarette smoke (33.9 % vs. 49.8 %).
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Table 1 Demographics of population, stratified by study site
Current Study Population (n = 618) Pabna (n = 317, 51.3 %) Sirajdikhan (n = 301, 48.7 %)
Number (%)
Sex
Male 307 (49.7) 156 (49.2) 151 (50.2)
Female 311 (50.3) 161 (50.8) 150 (49.8)
Stunting Status
Stunted 324 (52.4) 135 (42.6) 189 (62.2)
Not Stunted 294 (47.6) 182 (57.4) 112 (37.2)
Child Smoke Exposure
Exposed 260 (42.1) 158 (49.8) 102 (33.9)
Not Exposed 358 (57.9) 159 (50.2) 199 (66.1)
Mother's education
Primary or less 285 (46.1) 141 (44.5) 144 (47.8)
Secondary or greater 333 (53.9) 176 (55.5) 157 (52.2)
Mother's Protein
Low 139 (22.5) 1 (0.3) 138 (45.8)
Medium 336 (54.4) 184 (58.0) 152 (50.5)
High 143 (23.1) 132 (41.6) 11 (3.7)
Mean (SD)
Birth Gestational Age (weeks) 37.9 (2.0) 37.1 (2.0) 38.8 (1.6)
Missing 2 2 0
Age (months) 28 (2.9) 27.8 (2.8) 28.3 (3.0)
Mother's Weight at Enrollment (kg) 46.6 (7.6) 45.1 (7.1) 48.1 (7.9)
Mother's Height (cm) 151.4 (5.6) 151.1 (5.1) 151.7 (6.2)
Child's Birth Weight (kg) 2.85 (0.4) 2.8 (0.5) 2.9 (0.3)
n (%)≤ 2.5 kg 90 (14.6) 71 (22.4) 19 (6.3)
Child's Birth Length (cm) 46.6 (2.4) 46.9 (2.3) 46.2 (2.5)
HOME Score 42.7 (2.6) 41.5 (2.7) 44 (1.8)
Missing 0 0 1
Maternal Depression 15.2 (2.8) 15.3 (2.1) 15.1 (3.5)
Missing 272 125 147
Table 2 Heavy metal exposure distribution
Total Study Population Pabna Sirajdikhan
(n = 618) (n = 317) (n = 301)
Median (IQR)
Umbilical Cord Blood Lead (μg/dL) 3.1 (1.6–6.3) 1.6 (1.1–2.4) 6.2 (4.0–9.4)
n (%)≥ 5 μg/dL 206 (33.3) 17 (5.4) 189 (62.8)
Blood Lead 20–40 months (μg/dL) 4.2 (1.7–7.6) 1.7 (1.7–3.7) 7.3 (5.3–8.2)
n (%)≥ 5 μg/dL 282 (45.6) 43 (13.6) 239 (79.4)
Average Water Arsenic (μg/L) 13.4 (1.9–66.3) 34.6 (8.2–120.7) 3.3 (1.2–19.5)
Average Water Manganese (μg/L) 625.5 (368.6–1066.0) 569.0 (344.3–993.3) 750.3 (431.8–1148.0)
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Additionally, the metal exposure profiles differ between
the two study sites. Compared to children from Pabna,
children from Sirajdikhan were more likely to have blood
lead levels that exceed the Centers for Disease Control
and Prevention (CDC) lead exposure reference level of
5 μg/dL for children aged 1–5 [30], both at birth (62.8 %
vs. 5.4 %) and at 20–40 months of age (79.4 % vs. 13.6 %).
Additionally, compared to children from Pabna, children
from Sirajdikhan had higher average manganese exposure
(median μg/L [IQR]: 750.3 [431.8–1148.0] vs. 569.0
[344.3–993.3]), but lower average arsenic exposure (me-
dian μg/L [IQR]: 3.3 [1.2–19.5] vs. 34.6 [8.2–120.7]).
Demographic characteristics of stunted versus non-
stunted children were also examined (Table 3). Of all chil-
dren in this study, 52.4 % were classified as stunted. As
compared to their non-stunted peers, these stunted chil-
dren were less likely to be exposed to cigarette smoke
(38.6 % vs. 45.9 %) and less likely to have mothers who
had achieved a secondary education or greater (47.5 % vs.
60.9 %). In addition, as compared to non-stunted children,
stunted children had lower average water arsenic concen-
tration (mean μg/L [sd]: 48.4 [88.0] vs. 68.1 [130.7]), but
higher average water manganese exposure (mean μg/L
[sd]: 813.3 [582.2] vs. 745.1 [554.6]). Stunted children also
had a higher mean blood lead level at 20–40 months as
compared to non-stunted children (mean μg/dL [sd]: 6.2
[5.0] 4.6 [4.1]).
Because the sample under study is a subset of a larger
population-based cohort, we evaluated selection bias by
comparing the distribution of participant demographics
and exposure profiles between our included study popu-
lation and the excluded population. Evaluation of the
distribution of demographics between our study popula-
tion and the excluded population show important differ-
ences only between the age of the child at the second
lead collection time point (p = 0.03) and the measure of
mother’s protein consumption (p < 0.01) (see Additional
file 1: Table S1). No important differences were found in
exposure distributions for blood lead at either time
point, for water arsenic, or for water manganese (see
Additional file 1: Table S2).
Table 4 displays the results of multivariable regression
models for the association between lead exposure at
birth and at 20 to 40 months of age and stunting at 20
to 40 months. In both models, lead exposure at 20 to
40 months was modeled allowing for a quadratic associ-
ation. Of the confounders considered, this model re-
vealed the strongest predictors of stunting status to be
mother’s education, height, and protein intake during
pregnancy. No other potential confounders included in
the model were found to be significant predictors of
stunting status.
The association between concurrent lead exposure
and stunting was found to be non-linear, with an
increasing probability of stunting at higher lead levels
(Fig. 1). These results further indicate a significant
positive association between blood lead at 20 to
40 months and stunting at 20 to 40 months (OR = 1.12;
95 % confidence interval [CI]: 1.02–1.22). No significant
association was found between blood lead level at birth
and stunting at 20 to 40 months (OR = 0.98; 95 % CI:
0.95–1.01). The odds of stunting at 20 to 40 months
Table 3 Demographics and metal exposures of study
population, stratified by stunting status







Male 159 (49.1) 148 (50.3)
Female 165 (50.9) 146 (49.7)
Stunting Status
Stunted 324 (52.4) –
Not Stunted – 294 (47.6)
Child Smoke Exposure
Exposed 125 (38.6) 135 (45.9)
Not Exposed 199 (61.4) 159 (54.1)
Mother's education
Primary or Less 170 (52.5) 115 (39.1)
Secondary or Greater 154 (47.5) 179 (60.9)
Mother's Protein
Low 101 (31.2) 38 (12.9)
Medium 168 (51.9) 168 (57.1)
High 55 (17.0) 88 (29.9)
Mean (SD)
Birth Gestational Age (weeks) 38.0 (2.0) 37.9 (2.0)
Missing 2 0
Age (months) 28.1 (2.9) 28.0 (2.9)
Mother's Weight at Enrollment (kg) 46.0 (7.4) 47.2 (7.8)
Mother's Height (cm) 150.4 (5.6) 152.4 (5.5)
Child's Birth Weight (kg) 2.9 (0.4) 2.9 (0.4)
Child's Birth Length (cm) 46.2 (2.7) 46.9 (2.0)
HOME Score 42.7 (2.5) 42.7 (2.7)
Missing 1 0
Maternal Depression 15.0 (2.9) 15.4 (2.8)
Missing 141 132
Heavy Metal Exposures Mean (SD)
Umbilical Cord Blood Lead (μg/dL) 5.1 (5.2) 4.9 (7.8)
Blood Lead 20–40 months (μg/dL) 6.2 (5.0) 4.6 (4.1)
Average Water Arsenic (μg/L) 48.7 (88.0) 68.1 (130.7)
Average Water Manganese (μg/L) 813.3 (582.1) 745.1 (554.6)
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increase by 1.12 per one unit increase from zero in blood
lead level at 20 to 40 months.
For interpretability, an additional logistic regression
model was used to assess the relationship between an
increase from the first and third quartile of blood lead at
20 to 40 months and stunting. Results of this model
indicate that those children who have a blood lead level
greater than the third quartile of exposure at 20 to
40 months (7.6 μg/dL) have 2.6 (95 % CI: 1.4–5.0)
greater odds of being stunted as compared to children
who have a blood lead level below the first quartile of
exposure at 20 to 40 months (1.7 μg/dL).
A sensitivity analysis was conducted by adding an indi-
cator variable for clinic site to the previously described
multivariable logistic regression model. Results from this
clinic-adjusted model again indicate a non-linear rela-
tionship between blood lead at 20 to 40 months and
stunting status. These results support the findings from
the clinic-unadjusted model, again indicating a positive
association between blood lead at 20 to 40 months and
stunting at 20 to 40 months (OR = 1.15). This result,
however, was found to be borderline statistically signifi-
cant (p = 0.06; 95 % CI: 1.0–1.33). Again, no statistically
significant association was found between blood lead
level at birth and stunting at 20 to 40 months (OR =
0.97; 95 % CI: 0.93–1.00). Adjusting for clinic, the odds
of stunting at 20 to 40 months increase by 1.15 per one
unit increase in blood lead level at 20 to 40 months.
Discussion
Results of this study demonstrate a positive association
between concurrent blood lead concentration and stunt-
ing at age 20 to 40 months. In utero lead exposure was
also associated with stunting at age 20 to 40 months;
however, this association was not as strong and was not
statistically significant. This suggests that early child-
hood may be a critical window for the effect of lead on
stunting. Albeit slightly attenuated, this association was
shown to persist even after controlling for study clinic
site, providing further evidence for the robustness of this
finding.
The positive association between early life lead expos-
ure and stunting has been reported previously [31–34],
but several studies have cast doubt upon this relation-
ship by reporting no association between early life lead
exposure and stunting or inhibited vertical growth [35].
Attempts at investigating the relationship between mul-
tiple insults of lead exposure during early life and stunt-
ing have also reported inconsistent findings, with several
studies reporting insignificant findings [33], including
three longitudinal studies [36–38]. Other longitudinal
studies, however, have reported significant negative
effects of lead on the overall growth of children. One
such study, the Mexico City Prospective Lead Study,
highlights the negative association between childhood
head circumference at 6 months and prenatal maternal
blood lead levels [39]. Another study reported an associ-
ation between children’s lead levels and reduction in
stature at age 15 months, yet only among those children
whose mothers had a prenatal lead level greater than
7.7 μg/dL [40].
Failure to achieve full growth potential, particularly in
the form of stunting, has been shown to compromise
Table 4 Associations between blood lead level and stunting status
Unadjusted for
Clinic Site
Adjusted for Clinic Site
and Maternal Depression
OR CI OR CI
Blood Lead Level
Umbilical Cord Blood 0.98 0.95–1.01 0.97 0.93–1.00
20–40 months 1.12 1.02–1.22 1.15 1.00–1.33
Mother's Proteina 0.60 0.44–0.80 0.7 0.42–1.14
Mother's Education 0.78 0.63–0.96 0.71 0.53–0.94
Mother's Weightb 0.99 0.96–1.01 0.99 0.95–1.02
HOME Scoreb 0.96 0.89–1.03 0.97 0.88–1.06
Maternal Depressionb – – 0.97 0.89–1.06
Smoke Exposure 0.82 0.58–1.17 0.94 0.59–1.51
Mother's Height 0.94 0.91–0.97 0.93 0.88–0.97
Average Water Manganese 1.00 1.00–1.00 1.0 1.00–1.00
Average Water Arsenic 1.00 1.00–1.00 1.0 1.00–1.00
Clinic Site
Sirajdikhan – – reference
Pabna – – 0.57 0.27–1.18
aA measure of mother's protein was derived from frequency (times consumed
per week) of fish, meat and egg consumption
bThese measurements were taken at enrollment of the mothers, which
occurred at approximately 18 weeks into their pregnancy
Fig. 1 Predicted probability of stunting due to lead exposure at
20-40 months
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overall childhood development, resulting in both imme-
diate and long-term negative health outcomes. Because
it reflects the accumulated, permanent, and long-term
effects of deficiency in early childhood nutrition, stunt-
ing is widely considered the best epidemiological indica-
tor for assessing chronic malnutrition [41]. Early life
stunting has been shown to be associated with increased
insulin resistance [42], altered fat metabolism [43],
increased risk for chronic disease [44], impaired immune
function [45], and increased risk of hypertension and
cardiovascular disease [46]. Compounding these later life
morbidities is the strong body of evidence consistently
demonstrating the association between stunting and
cognitive deficits [18, 20, 47]. In the absence of interven-
tion, this cognitive delay resulting from childhood stunt-
ing has been found to persist in later life [17]. Research
from randomized trials, however, shows that improving
child nutritional status and growth, is associated with
concurrent benefits in motor development, mental
development, and overall cognitive ability [48–50], yet
children who experience early life stunting fail to achieve
the same cognitive development as their never-stunted
peers [49, 51].
Although the positive association between early life
lead exposure and stunting has been established in the
literature, little research has been done to understand
potential windows of exposure for the susceptibility of
stunting due to lead. A large body of literature exists to
identify periods of opportunity for interventions to miti-
gate the effects of early life stunting [52, 53], yet such
literature excludes the effect of lead on stunting. By
identifying a growth period during which children are at
an increased risk of stunting from lead exposure, our
study is able to fill this gap in the literature. In doing so,
we demonstrate that nutritional interventions alone are
likely not sufficient to reduce later-life stunting in chil-
dren in developing countries, and that such intervention
programs should include reducing early life lead expos-
ure during this critical window of development.
Our finding identifying the heightened susceptibility to
the effects of lead on stunting during early childhood is
consistent with various studies attempting to provide a
mechanistic explanation for the association between
early childhood lead exposure and stunting. Animal
models suggest the possibility of several mechanistic
pathways for this association, including lead-induced
reduction in appetite in rats [54], the direct effect of lead
on growth plate development [55], and through disrup-
tion of early life bone accrual through disruption of
osteoclast activity in rats [56].
Studies have consistently shown the possible role of
lead alteration of hypothalamic-pituitary axis function
through altered release of human growth hormone
(GH) and insulin-like growth factor 1 (IGF-1). Rodent
studies have found an association between lead and
suppressed GH release from the pituitary and de-
creased IGF-1 concentration [57, 58]. Corroborating
these animal models is a recent prospective cohort
study that shows an association between increased
blood lead level in peripubertal boys and decreased
serum IGF-1 [59].
The findings from these animal models and the recent
cohort study offer a possible explanation for the inconsist-
ent findings in studies that examine the effect of nutri-
tional interventions on stunting. Previous research has
demonstrated that catch-up growth in stunted children is
possible both with [60] and without [61, 62] nutritional
interventions, yet children who experience early life stunt-
ing are consistently shorter than their non-stunted peers.
None of these studies adjust for the effect of lead on stunt-
ing or HG or IGF-1 secretion, leaving open the possibility
that early life lead exposure may play a role in the differ-
ential height seen between stunted and non-stunted
children even after catch-up growth occurs.
Although our research highlights the importance of
concurrent, rather than in utero, lead exposure in predict-
ing stunting at age 20 to 40 months, the precise timing of
this postnatal lead exposure is unknown. This study
makes the assumption that exposure levels during the first
20 to 40 months of age are constant. While the origin of
lead exposure in this population is unknown [7], it is likely
that child exposure to lead occurs at the household level.
Because this research required that all enrolled families
remain in the same household for the duration of partici-
pation, lead exposure likely remained constant during the
study period, thereby minimizing this limitation.
Because nutritional status is a well-documented pre-
dictor of early life stunting, our study is limited by our
inability to comprehensively adjust for the nutritional sta-
tus of the child. However, stunting is a form of protein-
energy malnutrition [63], and protein deficiency has been
shown to be a leading nutritional predictor of stunting
[64]. Adjusting for maternal protein intake is therefore
likely to capture much of the effect of nutritional status
on stunting, with the assumption that children are
exposed to similar protein levels as their mothers.
Finally, our study may be limited by unmeasured
confounding. While we considered both confounders
and predictors of childhood stunting, unmeasured con-
founding is possible. To account for such unmeasured
confounding, we ran a sensitivity analysis adding to our
multivariable regression model an indicator for study
clinic site. While including this variable adjusted for
unmeasured confounders between study sites, it is pos-
sible that it resulted in an over-adjusted model. Because
inclusion of this study clinic site variable may be either
important or superfluous, results are shown for both the
clinic adjusted and clinic unadjusted analyses.
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This study builds upon existing literature on lead expos-
ure and chronic malnutrition by bridging the gap between
environmental health and nutrition. Our use of blood
samples to measure child lead exposure allowed us to
have the most accurate measure of lead in utero and in
early childhood [65, 66]. We were additionally able to
adjust for a large number of potential confounders of the
relationship between lead exposure and stunting as well as
predictors of early life stunting. The prospective nature of
this study is another strength. Finally, by identifying a
critical window of exposure for the association between
lead exposure and stunting, this research helps to inform
broader public health interventions and provides insight
into effective intervention strategies for reducing global
stunting rates.
Conclusions
There is a significant association between stunting and
lead exposure at age 20 to 40 months. This association
persists, albeit slightly attenuated, when controlling for
study clinic site. Additional research is needed to iden-
tify when children are at greatest risk of lead-associated
stunting during the 20 to 40 month period.
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